Eli Lilly (LLY) continues to be highlighted as one of the top stocks to buy for June 2026, driven by the massive success of its weight-loss and diabetes medications www.forbes.com . The pharmaceutical giant's robust pipeline and strong earnings growth make it a defensive play in a volatile market www.forbes.com .

Healthcare Leadership

Analysts remain bullish on LLY's ability to capture significant market share in the expanding obesity treatment sector, providing a strong cushion against broader economic uncertainties www.forbes.com .